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ABSTRACT Site-directed mutagenesis was used to mutate aCys418 and (3Cys447 in the M4 domain of Torpedo califomica
acetylcholine receptor expressed in Xenopus laevis oocytes. The M4 region is a transmembrane domain thought to be located
at the lipid-protein interface. By whole-cell voltage clamp analysis, mutation of both a subunits to aTrp418 increased maximal
channel activity approximately threefold, increased the desensitization rate compared with wild-type receptor, and shifted the
EC50 for acetylcholine from 32 pM to 13 pM. Patch measurements of single-channel currents revealed that the aTrp418
increased channel open times -28-fold at 1 30C with no effect on channel conductance. All of our measured functional changes
in the aTrp418 mutant are consistent with a simple kinetic model of the acetylcholine receptor in which only the channel closing
rate is altered by the mutation. Our results show that changes in protein structure at the putative lipid-protein interface can
dramatically affect receptor function.
INTRODUCTION
The nicotinic acetylcholine receptor (AChR) is a ligand-
gated and cation-selective ion channel protein located in the
postsynaptic membranes of many nerve, muscle, and fish
electric organ cells. AChR from the marine electric ray Tor-
pedo californica can be easily obtained in large quantities,
and its structural and biochemical features have been exten-
sively characterized. The Torpedo AChR is a multi-subunit
integral membrane glycoprotein with four homologous poly-
peptide subunits, designated a, ,B, y, and 6, with a relative
stoichiometric ratio of a2g'A (for recent reviews see Stroud
et al., 1990; Galzi et al., 1991; Lingle et al., 1992; Pradier and
McNamee, 1992; Unwin, 1993a). A generally accepted
model for the topology of all subunits assumes that the trans-
membrane domains of each subunit are composed of four
hydrophobic domains (Ml, M2, M3, M4) (Claudio et al.,
1983; Devillers-Thiery et al., 1983; Noda et al., 1983), and
that both the N- and C-terminals are located on the extra-
cellular side (DiPaola et al., 1989; see Fig. 1). The M2 trans-
membrane segment of each subunit is believed to form the
lining of the aqueous channel pore (Hucho et al., 1986; Imoto
et al., 1988; Leonard et al., 1988; Charnet et al., 1990; Revah
et al., 1990, 1991; Villarroel et al., 1991; Bertrand et al.,
1992; Pedersen et al., 1992; Villarroel and Sakmann, 1992),
but the functions of the other domains are not clear.
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To understand the interrelationship between structure and
function is an important challenge in characterizing the
mechanism of action of the AChR. Selective chemical modi-
fications of cysteine residues in the AChR have been used
over the past 20 years as a powerful approach to probe
structure-function relationships (Huganir and Racker, 1982;
Kao et al., 1984; Clarke and Martinez-Carrion, 1986; Kao
and Karlin, 1986; Yee et al., 1986; Mosckovitz and Gershoni,
1988; Marquez et al., 1989). Early attention focused on the
pair of cysteines at the ACh binding site (Kao et al., 1984;
Kao and Karlin, 1986). In addition, chemical modification of
free thiol groups by either N-(l-pyrenyl)maleimide (PM) or
N-phenylmaleimide (NPM) of Torpedo AChR under nonre-
ducing conditions led to inhibition of ion channel activity
without a detectable effect on ligand binding (Clarke and
Martinez-Carrion, 1986; Yee et al., 1986).
Efforts to resolve which cysteines are located in func-
tionally sensitive domains have continued. The 'yCys4l6 and
yCys420 residues in the amphipathic MA helix located in the
cytoplasmic domain between the M3 and M4 segment of the
y subunit and the yCys451 in the M4 transmembrane seg-
ment have been identified as the principal sites labeled by
NPM. These sites have been studied by site-directed muta-
genesis and expression in Xenopus laevis oocytes (Pradier
et al., 1989; Li et al., 1990). Mutations of the yCys4l6 and/or
yCys420 to Phe or Ser did not show significant functional
effects (Pradier et al. 1989), whereas mutations of the
,yCys451 to Phe or Ser showed substantial inhibition of the
channel activity (Li et al., 1990) as measured electrophysi-
ologically by whole-cell current responses to ACh. A cys-
teine in the Ml transmembrane segment of the a subunit
(aCys222) can be selectively labeled by PM (Marquez et al.
1989), and mutation of this Cys to Ser (Mishina et al., 1985)
in Torpedo AChR or mutation of an equivalent cysteine in
the a subunit ofmurine AChR to Ser (Lo et al., 1991) resulted
in no functional changes of the receptors.
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FIGURE 1 Position of the aCys418 in the globular
AChR. The two a subunits are shown white, and the (,
y, and 8 subunits are dark. Each subunit has four pu-
tative transmembrane domains (M1-M4) based on hy-
dropathy plots. The M4 domain is believed to be located
at lipid-protein interface and enlarged as an a-helix
here. The position of the aCys418 is shown as (0) and
is about in the center of M4.
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The inhibitory effects of alterations of cysteine residues in
the M4 region are somewhat surprising, since the M4 region
is believed to be located at the lipid-protein interface based
on independent chemical labeling studies (Giraudat et al.,
1985; Blanton and Cohen, 1992; see Fig. 1). In the work
presented here, we examine the functional roles of other cys-
teines at the presumed lipid-protein interface in Torpedo
AChR. The cysteine equivalent to the atCys418 in Torpedo
is highly conserved among the a subunits from different
species and in the Torpedo A subunit. The chemical status of
the aCys418 and aCys412 in Torpedo AChR remain un-
certain, since they are insensitive to alkylating agents and
could be disulfide bond-linked, fatty acylated, or unusually
unreactive (Mosckovitz and Gershoni, 1988). Fig. 1 shows
the relative position of the aCys418 in a schematic repre-
sentation of AChR structure. In this paper, we focus on dif-
ferent amino acid substitutions of the Cys418 in the, a subunit
of Torpedo AChR and a similar cysteine in the 3 subunit
(,BCys447) to investigate structure-function relationships in-
volving the M4 domain. In preliminary experiments we ob-
served an increase in the normalized whole-cell current re-
sponses for the aTrp418 mutant at very low ACh
concentrations (Li et al., 1992). Our present whole-cell volt-
age clamp and single-channel current measurements reveal
that mutations in the M4 region lead to dramatic changes in
several aspects of AChR function, including maximum nor-
malized channel activity, desensitization rates, EC50 of the
ACh dose-response curve, and mean channel open times.
MATERIALS AND METHODS
Materials
Enzymes for recombinant DNA manipulation were purchased from New
England Biolabs (Beverly, MA). Taq DNA polymerase and DNA ampli-
fication kits were from Perkin-Elmer Cetus (Norwalk, CT). Oligonucleo-
tides for polymerase chain reaction (PCR) and DNA sequencing were or-
dered from American Synthesis (Pleasanton, CA). All other reagents were
obtained from standard suppliers.
Mutations on the a and subunit of
Torpedo AChR
The coding region of the a subunit of Torpedo AChR was subcloned from
pa (Pradier et al., 1989) into the HindIII and EcoRI sites of the pGEM3Z(-)
vector from Promega (Madison, WI). Directed mutagenesis of the aCys418
was carried out by mismatch amplification using two sequential PCRs
(Horton and Pease, 1991). Mutagenic primers were synthesized containing
the desired DNA sequence extending about 11 bases on each side of the
mismatched region. Flanking primers (-20 mers) were designed to rec-
ognize sequences outside the BglII restriction site in the coding region of
the a subunit and the EcoRI site on the vector portion of the plasmid.
Amplification reactions were performed in a DNA thermal cycler (Perkin-
Elmer Cetus) for 30 cycles with denaturation for 1 min at 94°C, annealing
for 3 min at 48°C, and polymerization for 3 min at 72°C. The reaction
mixture of the first reaction contained 100 ,ul of 50 mM KC1, 10 mM
Tris-HCl (pH 8.3), 1.5 mM MgCl2, 0.01% gelatin, 200 ,uM each of dNTP,
100 ng DNA plasmid, 1 ,ug each of primer, and 2.5 units of Taq polymerase.
The conditions for the second PCR were identical to those for the first one,
except that the first PCR products were used instead of the DNA plasmid.
The amplified DNA was purified using GeneClean (Bio 101, La Jolla, CA)
and then digested with BglII and EcoRI. The final fragment (-900 bp) was
purified by GeneClean again and ligated back to the expression plasmid. The
resulting mutants were sequenced using the Sequenase 2.0 (United States
Biochemical Corp., Cleveland, OH) for double-stranded DNA sequencing
to ensure that the desired mutation was present and no undesired base
changes had occurred. Mutation for ,BCys447 was carried out by the same
strategy but BstXI and SacII were used as restriction sites.
In vitro RNA transcript synthesis and expression
in X. Iaevis oocytes
The linearized cDNA templates of a, (3, y, and 8 subunits of Torpedo
nAChR (pa, pX13, pXy, and SP64T8) (Pradier et al., 1989) were used for
in vitro transcription by SP6 polymerase in the presence of ribonucleotide
triphosphates and the cap analogue (m7G(5')ppp(5')G, 5' 7-methyl gua-
nosine residue). Purification of RNA transcripts was performed using Se-
lect-D(RF) columns (5 Prime-3 Prime Inc., West Chester, PA) according to
the manufacturer's directions.
Ovarian lobes were obtained from anesthetized female X. laevis through
a ventral incision about 1 cm in length, and the wounds were closed with
two or three stitches of sterile catgut. Follicle cell layers were removed by
incubation of the oocytes in Ca2+-free OR2 buffer (Wallace et al., 1973)
containing 82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 1 mM Na2HPO4,
426 P
425 V
422 T
421 G
415M
414F
411 L
410L
647Lee et al.
Volume 66 March 1994
and 5 mM HEPES, pH 7.6, plus 2 mg/ml collagenase (type 1A, Sigma
Chemical Co., St. Louis, MO) for 20 min at room temperature under slow
agitation (80-100 rpm) followed by manual defolliculation. Oocytes of
stage V or VI were chosen for injection. Fifty nanograms (at a concentration
1 ng/nl) of the a, ,3, -y, and 8 subunit transcripts of Torpedo AChR with the
ratio of 2:1:1:1 were injected into the cytoplasm ofXenopus oocytes. After
injection, the oocytes were incubated at 18-19TC in a medium (Heasman
et al., 1991) containing 50% Leibovitz's L-15 media (GIBCO, Gaithersburg,
MD), 0.4 mg/ml bovine serum albumin; antibiotic-antimycotic was added
according to the manufacturer's directions (catalog no. 600-5245AE,
GIBCO). The medium was changed daily.
Electrophysiological procedures
Voltage clamp
Voltage clamp experiments were performed on oocytes 48-96 h after in-
jection at room temperature using an Axoclamp 2A (Axon Instruments,
Burlingame, CA) in the two-electrode voltage clamp configuration. Under
voltage clamp, membrane currents were continuously recorded digitally
using the SCAN program (Dagan Corp., Minneapolis, MN) on an 80386-
based microcomputer through a TL-1 interface (Axon Instruments). Mi-
croelectrodes were prepared using an electrode puller (model P-87, Sutter
Instruments, Novato, CA) from 1.5 mm OD/0.84 mm ID glass capillaries
(World Precision Instrument, Sarasota, FL, catalog no. 1B15OF-4) and filled
with 3 M KCl. Voltage electrodes were 10-20 MQl and current electrodes
were about 1 Mfl in resistance. Voltage clamp recordings were made at a
holding potential of -80 mV to correspond to the single-channel measure-
ments (see below) with series resistance compensation. The original external
buffer in our preliminary reports (Li et al., 1990; Li et al., 1992) was MOR2
buffer (82mM NaCl, 2.5 mM KCl, 1 mM Na2HPO4,5 mM MgCl2, 0.2mM
CaCl2, and 5 mM HEPES, pH 7.4). To decrease the ACh-induced whole-cell
current, the present experiments used an external solution modified from
MOR2 buffer by adding EGTA to chelate the free Ca2' and by substituting
half of the NaCl concentration with Tris-HCl. The new buffer contained 66
mM Tris-HCl, 41 mM NaCl, 2.5 mM KCl, 1 mM Na2HPO4, 5 mM MgCl2,
0.2 mM CaCl2, 5 mM HEPES, and 0.5 mM EGTA, pH 7.4. Solutions
containing ACh were freshly prepared immediately before measurement
from a 1 M ACh stock solution, which was stored at -20°C. Volume of the
oocyte chamber was 1.5 ml. Perfusion rates were 15 ml/min.
The normalized channel activity is defined as the peak of ACh-induced
current (nA) per femtomole of surface a-bungarotoxin binding sites (see
below). Dose-response measurements for wild-type and each mutant AChR
were repeated on at least three oocytes. Data points of dose-response curves
were calculated from the peak currents at each concentration. Data points
up to 300 ,M ACh were fitted with a curve of the form Y = 100/(1 +
(Kd/A)n) using nonlinear regression. Hill coefficients and EC50s (ACh con-
centrations that give 50% response of maximum normalized activity) were
determined from the fitted curves (Table 1). The calculated EC50s and Hill
coefficients do not include ACh concentrations higher than 300 ,uM. By
considering that the EC50 may be influenced by desensitization of AChR,
peak currents were also corrected due to attenuation by desensitization. Fifty
percent of the peak responses were taken as zero time (Cachelin and
Colquhoun, 1989), and the current traces were fitted with one exponential
decay. Corrections for the attenuation were performed by extrapolation of
the fitted equation back to zero time to obtain the corrected values of peak
current. EC50s from these corrected values were not significantly different
from the uncorrected values which are listed in Table 1.
Single-channel recording
Oocytes expressing the Torpedo AChR were transferred to a hypertonic
solution composed of 150 mM NaCl, 2 mM KCl, 5 mM HEPES, and 3%
sucrose (pH 7.6) for 15-30 min to induce osmotic shrinkage. The vitelline
membrane was removed manually, and the oocytes were transferred to the
recording chamber and washed with 5-10 volumes of a bath solution con-
sisting of 100 mM KCl, 1 mM MgCl2, 10 mM HEPES (pH 7.2). Patch
pipettes were made of thick-walled (0.64 mm) borosilicate glass (Sutter
Instruments) and had resistances from 7 to 11 Mfl. The pipette (external)
solution was composed of 100 mM KCl, 10 mM HEPES, 10 mM EGTA
(pH 7.2), and 1-4 ,uM ACh. Single-channel currents were recorded using
the on-cell patch configuration (Hamill et al., 1981) using a L/M-EPC 7
patch-clamp amplifier interfaced to a Cheshire Data Interface and DEC LSI
11/73 computer system (INDEC Systems, Sunnyvale, CA) or a Dagan 3900
amplifier interfaced with a TL-1 DMA (Axon Instruments) to a Everex 386
computer. After a gigaohm seal formation (>10 Gfl), the chamber was
cooled to the desired temperature and the data recorded on VHS tapes
for later analysis using a modified digital audio processor (VR-1OB and
VR-1OC, Instrutech Corp., Mineola, NY).
Data analysis was performed using pCLAMP software (Axon Instru-
ments) to generate data files. The data reduction step was performed using
the IPROC V.3 software programs also distributed by Axon Instruments. All
the data generated in this way were filtered at 4 kHz and sampled at 100
,us. Single-channel conductance was calculated from the slope of the
current-voltage curves. Open times were calculated from steady-state re-
cordings at -80 mV using a half-amplitude criterion. The measurable short-
duration closures in channel openings that are seen in most AChR activity
were not evident in our recording, even at higher temporal resolution, in-
dicating that under these conditions there is only one opening per burst.
Radioligand binding assay
Binding assays using [125I]a-bungarotoxin (Amersham Life Sciences, Ar-
lington Heights IL, -74 TBq/mmol) were performed according to the con-
ditions described by Li et al. (1990). Briefly, the surface binding reactions
were performed on the same intact oocytes immediately after the voltage
clamp measurement by moving each oocyte into a 80-gl reaction solution
containing 1 nM ['"-I]a-bungarotoxin and 0.5 mg/ml bovine serum albu-
min. The samples were incubated for 2 h at 250C and the reaction was
TABLE 1 Functional consequences of aCys418 and j3Cys447 mutations
AChR % peak activity
mutation Peak activity EC50 Hill coefficient* relative to wild type
(nA/fmol) ,uM
Wild type 225 ± 37 (n = 4) 32 ± 10 1.9 0.4 (n = 4) 100
aTrp418 638 + 138 (n = 6) 13 ± 3 1.5 +0.3 (n = 4) 283
aPhe418 542 ± 157 (n = 4) 18 ± 6 2.6+ 0.3 (n = 3) 241
aAla418 228 ± 70 (n = 3) 48 ± 7 1.3 0.1 (n = 2) 101
aGly418 121 ± 24 (n = 2) 10 ± 1 2.3 0.2 (n = 2) 54
,BTrp447 292 ± 19 (n = 2) 24 ± 9 2.2 0.5 (n = 2) 130
Data are given as means ± S.E. Numbers in parentheses indicate the number of oocytes tested. Normalized peak channel activity for each oocyte was obtained
from peak of ACh-induced current (nA) at 300 ,uM ACh divided by the surface a-bungarotoxin binding data on the same oocyte. Data points from all ACh
concentrations were fitted with the Hill equation Y = 100/(1 + (Kd/A)n). Hill coefficients and EC50s were determined from these fits.
* Hill coefficients from mutants are not significantly different from wild-type receptor by t-test examination.
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terminated by washing the oocytes four times with MOR2 buffer. Non-
specific binding was determined by incubating radioactive toxin with un-
injected oocytes and was usually less than 5% of the specific binding data.
Radioactivity was measured by liquid scintillation counting (Packard Tri-
Carb 1500). A calibration curve was obtained by counting 0-20 ,ll of 1 nM
[1'2I]a-bungarotoxin solution (equivalent to 0-20 fmol).
RESULTS
Mutations of a single cysteine residue on the a
subunit alter the size of responses to ACh
Preliminary data in our laboratory showed that the mutation
from the aCys418 to Trp dramatically increased the apparent
channel activity based on limited voltage clamp experiments
at 0.2 and 1 ,uM ACh (Li et al., 1992). In the experiments
presented here, we changed this aCys418 to several different
amino acids and carried out a far more extensive electro-
physiological analysis to investigate the functional role of
this Cys in the M4 domain of AChR. Mutations at the
aCys418 position of T. californica AChR to Trp, Phe, Ala,
or Gly were carried out using directed mutagenesis as de-
scribed in Materials and Methods. A homologous cysteine in
the ,3 subunit was also mutated to Trp by the same strategy.
Synthesized oligodeoxynucleotides containing mutated
codons of desired mutants were used and two-step PCRs
were performed to generate DNA fragments containing the
mutations. DNA sequencing was carried out to confirm the
entire sequence.
The maximum ACh-induced currents were observed at
300 ,uM ACh. The maximum channel activities normalized
to the number of a-bungarotoxin binding sites for each mu-
tant receptor are listed in Table 1. The results demonstrate
that the aTrp418 mutation increases the maximum channel
activity to 283% of wild-type AChR, the aPhe418 mutation
increases it to 241%, the ,BTrp447 mutation increases it to
130%, the aGly418 mutation decreases it by -50%, and the
aAla418 mutation gives the similar maximal activity as wild
type. Thus mutant receptors with bulky aromatic side chains
(Trp and Phe) at the a418 position show larger maximum
channel activities and a mutant with a smaller side chain
(Gly) decreases channel activity; replacement of aCys418
with Ala, which has a similar size, had little effect on maxi-
mum normalized response to ACh.
Because of the dramatic functional increase of this
aTrp418 mutant, the whole-cell current saturated our voltage
clamp amplifier when responses were obtained at high ACh
concentrations in standard buffer solution (MOR2 buffer; see
Materials and Methods). To prevent this, the extracellular
solution was altered to decrease the current by substituting
half of the NaCl concentration with Tris-HCl as described in
Materials and Methods. In addition, EGTA was added to
chelate the free Ca2" in the extracellular buffer to prevent
activation of the Ca2" activated Cl- channel, which is en-
dogenous in X. laevis oocytes (Barish, 1983; Mishina et al.,
1985; White et al., 1987). An alternative solution of decreas-
ing the amount of mRNA injected was less desirable, since
a consistently high level of AChR expression is required to
a-bungarotoxin binding assay is essential for obtaining nor-
malized measurements of channel activity, expressed in nA
current per fmole toxin binding sites in each individual oo-
cyte (Li et al., 1990), that can be compared among oocytes
and between mutants. By injecting 50 ng ofRNA mixture for
AChR, we found the typical expression level to be 3.4 ± 1.8
(n = 7) fmol per oocyte. None of our mutants showed al-
terations in the expression level in the toxin-binding assay.
Because the aTrp418 showed very high channel activity, 40
ng of RNA mixture was routinely used for oocyte injection
to obtain sufficiently high expression ofAChR without satu-
rating our voltage clamp amplifier.
Examples of dose-response curves for wild type and each
of the mutant AChRs are shown in Fig. 2. The aTrp418,
aPhe418, and 3Trp447 AChR mutations increased the nor-
malized response to ACh compared with the wild type at all
concentrations from 1 ,uM to 1 mM ACh. In contrast, the
aAla418 mutation slightly decreased the responses at low
ACh concentrations, with almost the same maximum re-
sponse as wild type, and the aGly418 mutation slightly in-
creased the responses at low ACh concentrations but gave
half of the maximum response of wild-type AChRs. Hill
coefficients and EC50s (ACh concentrations that give 50%
response of maximum normalized activity) for each dose-
response curve, calculated as described in the Materials and
Methods, are listed in Table 1. The Hill coefficients from the
mutants shown in Table 1 are not significantly different from
the wild-type value of 1.9, indicating that these mutants in-
duce no dramatic changes in cooperativity.
The aTrp418 mutation increases desensitization
rates
The aTrp418 mutant was further characterized as a prototype
for the mutations, since this mutant had the largest effect on
800-
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600- o aTrp418
O o aPhe418
4* Trp447
400-
m Wild type
300 cxAla4l8
200 * aGly4l8
100-
0 1 2 3
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FIGURE 2 Representative dose-response relations for different X. laevis
oocytes expressing wild-type or mutant AChRs. Currents are expressed as
ACh-induced current (nA) per fmol of surface a-bungarotoxin binding sites.
Data points were fitted to the Hill equation Y = 100/[1 + (KdIA)n], where
Kd is the apparent dissociation constant, equivalent to the EC50 or the ACh
concentration inducing 50% maximal channel activity, n is the Hill coef-
accurately measure surface bungarotoxin binding. The
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receptor function. Representative sets of current responses in
oocytes expressing wild-type or the aTrp418 mutant AChR
are shown in Fig. 3 to illustrate the effects of the mutation
on desensitization at different ACh concentrations. Desen-
sitization rates increased with increasing ACh concentrations
in oocytes expressing both wild-type and mutant AChRs.
However, the aTrp418 mutant showed significantly faster
desensitization rates compared with the wild type at all ACh
concentrations. We used the average time for the current to
decline to half of its peak amplitude, t1/2, as an indication
of the desensitization time course. Average tj/2 values
were more than fourfold longer in oocytes expressing
wild-type AChR at 300 ,uM ACh (t/2 > 60 ± 8 s, n = 3)
than in those expressing the aTrp418 mutant AChR (tj/2 =
15 + 3 s, n = 5).
The aTrp418 mutation increases channel
open time
Patch clamp recordings of single-channel currents for the
aTrp418 mutant showed a marked increase in mean open
time compared with the wild-type (aCys418) channels.
Fig. 4 A shows currents recorded from on-cell patches in
oocytes expressing wild-type and the aTrp418 mutant
AChRs. The increase in the duration of channel openings
can be seen in the open time distributions for both channel
types shown in Fig. 4, C and D. Note that the time scale
for the mutant distribution has been compressed relative to
the wild-type distribution. At 13 ± 10C, our normal tem-
Wild type
3
300
aiTrp418
3
-100
300
FIGURE 3 Representative current traces showing normalized ACh-
induced current from wild-type and the aTrp418 receptors. ACh concen-
trations were 3, 10, 30, 100, and 300 ,iM as indicated on the figure. Currents
are normalized to ACh-induced current per fmol of surface a-bungarotoxin
binding sites. Calibration bars are 100 nA/fmol and 5 s. Desensitization rates
of the mutant receptors are faster at all ACh concentrations.
perature for single-channel recording, wild-type channels
showed a mean open time T = 0.6 ± 0.01 ms (n = 8
patches; 4 batches of oocytes). The mean open time of the
aTrp418 channels was T = 16.5 ± 0.06 ms (n = 10
patches; 3 batches of oocytes), representing a 28-fold in-
crease from wild type. At higher temperatures the apparent
magnitudes of the increase in channel open time were
somewhat less (e.g., -23-fold at 17°C) but remained sub-
stantial at all temperatures between 11°C and 22°C. There
was no significant difference for either wild-type or the
aTrp418 receptor in channel conductance and open times
recorded on different days after mRNA injection. Fig. 4 B
shows that this mutation did not alter the permeability
properties of the channel, since both the conductance and
the reversal potentials were unchanged. The conductance
value for the wild-type receptor was 65 ± 4 pS (n = 9
patches; 4 batches of oocytes) and for aTrp418 was 66 +
2 pS (n = 7 patches; 3 batches of oocytes).
DISCUSSION
The M4 domain of AChR is postulated to be at the lipid-
protein interface but not part of the ion channel or ligand-
binding domains (Pradier and McNamee, 1992). The ability
of a single mutation at the postulated lipid-protein interface
of the ACh receptor to dramatically alter ion channel function
is a somewhat unexpected observation. Previous studies of
lipid effects on AChR structure and function have suggested
a significant linkage between lipid composition and receptor
function (Fong and McNamee, 1987; Pradier and McNamee,
1992; Bhushan and McNamee, 1993), but specific effects at
the amino acid level have not yet been proposed. We will
focus the discussion on the aCys418 to aTrp418 mutant,
because it had the largest effects on channel activity. Com-
pared with wild-type receptor, the aTrp418 mutant increased
the maximal normalized channel activity threefold, shifted
the EC50 of the ACh dose-response curve from 32 ,uM to 13
,uM, and increased desensitization rates. At the single-
channel level, there was a 20- to 28-fold increase in channel
mean open time. There were no changes in single-channel
conductance, current-voltage relationships, or reversal po-
tentials. Because of the dramatic change in channel open
time, we examined a relatively simple kinetic model of
AChR function to see whether the change in open time was
sufficient to explain all the functional changes observed at
both the single-channel and whole-cell level. The starting
point for our analysis is
K, K2 1
R =AR = A2R ± A2R*
where R is the receptor, A is ACh, AR and A2R are the mono-
and bi-liganded species, and A2R* is the open (conducting)
state of the receptor-ligand complex. K1 and K2 are the dis-
sociation constants for the first and second ligand binding
steps, respectively; 13 is the channel opening rate constant,
and a is the channel closing rate constant (equal to 1/mean
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FIGURE 4 Mutation to aTrp418 increased channel
open times but did not alter channel conductance. (A)
Current records of channel openings from wild-type and
the aTrp418 mutant AChRs recorded from on-cell
patches. Holding potential was -80 mV, ACh concen-
tration in the pipette was 4 pLM, and the bath temperature
was 12 ± 1°C for both records. Records were sampled at
100 ,us and filtered at 4 kHz. Closed channel level is
denoted at the beginning of each record by a small dash.
Calibration bars are 5 pA and 20 ms. (B) Current-voltage
relationship for wild-type (0) and the aTrp418 (0)
AChRs. The mean conductance values were calculated
from the slope of individual I-Vs and pooled together.
wild-type conductance was y = 65 ± 4 pS (n = 9 patches;
4 oocyte batches) and the aTrp418 conductance was
66 + 2 pS (n = 7 patches; 3 oocyte batches). The solid
line represents the best fit line for the wild-type data. (C)
A characteristic open time distribution for wild-type
channels. This patch was held at -80 mV and kept at
14°C. The bin width in is 0.1 ms/div, and this distribution
contains 1865 counts. The mean open time for this par-
ticular patch was 0.6 ± 0.01 ms. (D) Open time distri-
bution for the aTrp418 channels. The patch was held at
-80 mV and kept at 13°C. The mean open time for this
patch is 16.5 ± 0.06 ms. The bin width was 1 ms/div; the
histogram contains 2374 counts.
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open time). According to the above scheme, the following
equation is obtained:
[A2R*] [A2R*]
Rtotal [R] + 2[AR] + [A2R] + [A2R*]
Letting K2 = aK1, where a is a constant, and simplifying,
we have
[A2R*] [A]2
= o~~~~~~~~~~~2
Rtoti (a/p)(aK2 + 2aK1[A] + [A]2) + [A]2
With given K1, a, and a/P ratio, the theoretical dose-response
curve for the AChR can be plotted. At high ACh concen-
trations, the maximum response is directly correlated with
the a/13 ratio. Letting the a/13 ratio be 20-fold smaller than
wild type (corresponding to a 20-fold decrease in the value
of a) for the aTrp418 mutant can simulate the increase in
maximal response and the decrease in EC50. For example,
changing the a/,B ratio from a postulated value of 2 for wild
type to 0.1 for the aTrp418 mutant could quantitatively ex-
plain the threefold increase in maximal response observed
and also the decrease in EC50. If the model is expanded to
include channel blocking by ACh (Sine et al., 1990), lower
values of the wild-type a/f3 ratio (e.g., 0.7 from their mea-
surements in Ca2+-free solution at 22°C) will also simulate
an increase in maximal response and a decrease in EC50 when
the a is reduced by a factor of 20. Thus a change in a single
parameter (a) could account for all the observed macroscopic
changes.
The increased rate of desensitization observed for the
aTrp418 mutant could also be a consequence of the increased
open time. Desensitization processes have been proposed
from some (or all) of the closed states, from the open state,
or from all states (Pradier and McNamee, 1992). If the rate
of desensitization is proportional to the relative proportion of
receptors in the A2R* state, this model predicts desensiti-
zation will be about threefold faster for the aTrp418 muta-
tions than the wild-type AChR, in agreement with the four-
fold difference in t1/2 we measured. Thus, the data provide
support for models in which the open channel form is a
predominant pathway for desensitization as proposed by
Cachelin and Colquhoun (1989).
Although the M4 segment of AChR is suggested to be
located at the lipid-protein interface, it is not clear how mu-
tations in this region alter ion channel function. A reasonable
hypothesis is that mutations will alter helix-helix interac-
tions. If the M4 is an a-helix as in Fig. 1, the amino residues
on the right-hand side, which include the aCys418 in Tor-
pedo, are more conserved among species and might interact
with other domains. However, Blanton and Cohen (1992)
showed that the amino residues on this side of the helix can
be preferentially labeled by a nonspecific lipophilic probe,
and they suggested that this side is exposed to lipid. It is
remarkable that a mutation in a lipid-exposed region of an
a-helix could have such dramatic effects on channel func-
tion. Recently, Unwin (1993b) reported that the Ml, M3, and
M4 regions of AChR might form ,B-sheet structures rather
B
V (mV)
-1,
l (pA)
-8
D
aTRP-418
r = 16.5 ms
0 60 120
Time (ms)
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than a-helix conformations based on observations from elec-
tron microscopy. Fourier transform infrared measurement
from our laboratory (Butler and McNamee, 1993) also sug-
gest a high content of (3-sheet structure in the AChR. Our
future studies will examine other positions in the M4 domain
to identify patterns in modulating AChR function, with the
goal of discerning the secondary structure of the M4 and
allosteric linkages between the lipid-protein interface and the
ion channel domain.
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